Comparison of Pain, Sensitisation, Function and Quality of Life According to Stenosis Degree in Chronic Neck Pain
Launched by IZMIR DEMOCRACY UNIVERSITY · May 4, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how different levels of cervical stenosis, which is a narrowing of the spinal canal in the neck, affect pain, sensitivity, and overall quality of life in people with chronic neck pain. Central sensitization is a condition where even light touch or movement can cause significant pain, making it difficult for patients to engage in physical activities and enjoy their daily lives. By looking at factors like pain levels, movement abilities, and sensory changes, the researchers aim to gather important information that could help improve treatments and patient care for those suffering from neck pain.
To participate in the study, individuals must be between the ages of 65 and 74 and have experienced neck pain for at least three months. Participants will undergo various tests, including measuring their pain sensitivity and range of motion, as well as completing questionnaires about their quality of life. It's important to note that individuals who have had recent surgeries, severe pain that limits movement, or certain neurological or psychiatric conditions will not be eligible for this trial. This study aims to better understand how cervical stenosis impacts patients, which could lead to better pain management strategies and improved quality of life.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Cases whose stenosis classification can be clearly determined on MRI
- • Individuals with neck pain for at least 3 months
- Exclusion Criteria:
- • Individuals who did not agree to participate in the study
- • Individuals undergoing cervical surgery
- • Individuals with pain so severe that they cannot perform cervical movement
- • Individuals with a diagnosis of vertigo
- • Individuals with sudden hearing loss
- • Individuals with additional neurological disorders
- • Individuals with psychiatric and cognitive disorders that would prevent measurement in the study
About Izmir Democracy University
Izmir Democracy University is a forward-thinking academic institution dedicated to advancing research and innovation in the healthcare sector. As a clinical trial sponsor, the university emphasizes a commitment to ethical standards, scientific rigor, and interdisciplinary collaboration. With a strong focus on improving patient outcomes and contributing to public health, Izmir Democracy University leverages its academic expertise and state-of-the-art facilities to facilitate clinical research that addresses pressing medical challenges. The university actively engages in partnerships with healthcare professionals and organizations to drive meaningful advancements in clinical practice and health policy.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
İzmir, , Turkey
Patients applied
Trial Officials
Onur Engin, Assist Prof
Principal Investigator
Izmir Democracy University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported